This study evaluated the association between the HLA-G 14 bp ins/del polymorphism, HLA-G, ILT2 and ILT4 mRNA expression and clinical variables (age at onset, TNM staging system and p16 positivity) in HNSCC patients. The gene discussed is LILRB2; the disease is head and neck squamous cell carcinoma.